The US is in a Biotech boom , SSH is trading like a miner. Someone is accountable for the market cap despite we being told by management we have a product achieving outstanding results. Word of mouth should have spread out amongst those needing such treatment and ringing the company where they can get it. I know they are hiring a PR firm but the market investors in a Biotech boom should have SSH valued much much higher. As i mentioned before will heart failure treatment by C-Pulse impact THOR and HTWR valuations, would they rather see SSH disappear off the radar.
- Forums
- ASX - By Stock
- SHC
- march corporate update
march corporate update, page-22
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)